Brooks O'Neil
Stock Analyst at Lake Street
(0.86)
# 3,957
Out of 5,081 analysts
33
Total ratings
30.3%
Success rate
-18.87%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.72 | +115.05% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $19.93 | -39.79% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.51 | +127.92% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $5.62 | +255.87% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $85.02 | +29.38% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $30.40 | -1.32% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $20.44 | +247.36% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.88 | +277.91% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $44.52 | +23.54% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $21.23 | -15.21% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.99 | +0.20% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.96 | +72.41% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $27.95 | -6.98% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.42 | +2,512.21% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $33.64 | +279.01% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.72
Upside: +115.05%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $19.93
Upside: -39.79%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.51
Upside: +127.92%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $5.62
Upside: +255.87%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $85.02
Upside: +29.38%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $30.40
Upside: -1.32%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $20.44
Upside: +247.36%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.88
Upside: +277.91%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $44.52
Upside: +23.54%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $21.23
Upside: -15.21%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.99
Upside: +0.20%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.96
Upside: +72.41%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $27.95
Upside: -6.98%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.42
Upside: +2,512.21%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $33.64
Upside: +279.01%